MoonLake Immunotherapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $19 | $19 | $0 |
Gross Profit | -28 | -22 | 16 | -3 |
EBITDA | -30,550 | -19,797 | -15,025 | -12,973 |
EBIT | -30,578 | -19,820 | -15,028 | -12,976 |
Net Income | -24,267 | -13,673 | -7,437 | -9,426 |
Net Change In Cash | 0 | 19 | 19 | 0 |
Free Cash Flow | -27,890 | -15,160 | -12,628 | -9,250 |
Cash | 342,791 | 458,441 | 451,169 | 318,165 |
Basic Shares | 62,874 | 62,637 | 59,914 | 53,517 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 |
|---|---|---|
Revenue | $0 | $0 |
Gross Profit | -13 | -12 |
EBITDA | -54,109 | -65,049 |
EBIT | -54,123 | -65,061 |
Net Income | -36,007 | -64,506 |
Net Change In Cash | 0 | 0 |
Cost of Revenue | 31,458 | |
Free Cash Flow | -43,062 | -55,909 |
Cash | 451,169 | 39,505 |
Basic Shares | 49,122 | 29,361 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.39 |
2024-03-31 | -$0.22 |
2023-12-31 | -$0.12 |
2023-09-30 | -$0.18 |
